1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Armistice Capital, Llc Buys Celgene Corp, Madrigal Pharmaceuticals Inc, Pacira BioSciences Inc, Sells Clovis Oncology Inc, Tempur Sealy International Inc, Stericycle Inc

New York, NY, based Investment company Armistice Capital, Llc buys Celgene Corp, Madrigal Pharmaceuticals Inc, Pacira BioSciences Inc, Biogen Inc, Burlington Stores Inc, Target Corp, The Home Depot Inc, Assembly Biosciences Inc, Frontdoor Inc, AMAG Pharmaceuticals Inc, Diplomat Pharmacy Inc, Adamas Pharmaceuticals Inc, Dick's Sporting Goods Inc, National Beverage Corp, Campbell Soup Co, AutoZone Inc, bluebird bio Inc, Energizer Holdings Inc, Jack In The Box Inc, Nike Inc, Merck Inc, Brinker International Inc, Amazon.com Inc, Del Frisco's Restaurant Group Inc, Aileron Therapeutics Inc, Spotify Technology SA, Dropbox Inc, PetIQ Inc, Spectrum Pharmaceuticals Inc, Five Prime Therapeutics Inc, PTC Therapeutics Inc, Tyson Foods Inc, Aytu BioScience Inc, Cedar Fair LP, Cellectis SA, Zafgen Inc, Bellerophon Therapeutics Inc, Moleculin Biotech Inc, sells Clovis Oncology Inc, Tempur Sealy International Inc, Stericycle Inc, Regeneron Pharmaceuticals Inc, Progenics Pharmaceuticals Inc, Playa Hotels & Resorts NV, TJX Inc, JM Smucker Co, Mallinckrodt PLC, Voyager Therapeutics Inc, Alexion Pharmaceuticals Inc, Assertio Therapeutics Inc, Foot Locker Inc, CVS Health Corp, Enanta Pharmaceuticals Inc, Solid Biosciences Inc, Marker Therapeutics Inc, Alphatec Holdings Inc, Advance Auto Parts Inc, Incyte Corp, Vical Inc, Flexion Therapeutics Inc, Achillion Pharmaceuticals Inc, CRISPR Therapeutics AG, Naked Brand Group, Ollie's Bargain Outlet Holdings Inc, Oramed Pharmaceuticals Inc, Seelos Therapeutics Inc, Citius Pharmaceuticals Inc, Under Armour Inc, Achieve Life Sciences Inc, Pulmatrix Inc, Synthetic Biologics Inc, Neuralstem Inc, Tenax Therapeutics Inc, Ritter Pharmaceuticals Inc, Onconova Therapeutics Inc during the 3-months ended 2019Q1, according to the most recent filings of the investment company, Armistice Capital, Llc. As of 2019Q1, Armistice Capital, Llc owns 68 stocks with a total value of $1.8 billion. These are the details of the buys and sells.

For the details of ARMISTICE CAPITAL, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/armistice+capital%2C+llc/current-portfolio/portfolio

These are the top 5 holdings of ARMISTICE CAPITAL, LLC
  1. SPDR S&P 500 (SPY) - 1,600,000 shares, 24.77% of the total portfolio.
  2. Cerecor Inc (CERC) - 18,304,285 shares, 5.86% of the total portfolio. Shares added by 0.97%
  3. CVS Health Corp (CVS) - 1,250,000 shares, 4.10% of the total portfolio.
  4. Energizer Holdings Inc (ENR) - 1,296,000 shares, 3.19% of the total portfolio. Shares added by 21.35%
  5. Celgene Corp (CELG) - 592,000 shares, 3.06% of the total portfolio. New Position
New Purchase: Celgene Corp (CELG)

Armistice Capital, Llc initiated holding in Celgene Corp. The purchase prices were between $64.09 and $94.34, with an estimated average price of $87.12. The stock is now traded at around $94.96. The impact to a portfolio due to this purchase was 3.06%. The holding were 592,000 shares as of .

New Purchase: Madrigal Pharmaceuticals Inc (MDGL)

Armistice Capital, Llc initiated holding in Madrigal Pharmaceuticals Inc. The purchase prices were between $103.48 and $143.84, with an estimated average price of $124.23. The stock is now traded at around $106.68. The impact to a portfolio due to this purchase was 2.92%. The holding were 425,000 shares as of .

New Purchase: Pacira BioSciences Inc (PCRX)

Armistice Capital, Llc initiated holding in Pacira BioSciences Inc. The purchase prices were between $36.47 and $43.02, with an estimated average price of $39.13. The stock is now traded at around $45.60. The impact to a portfolio due to this purchase was 2.24%. The holding were 1,072,000 shares as of .

New Purchase: Biogen Inc (BIIB)

Armistice Capital, Llc initiated holding in Biogen Inc. The purchase prices were between $216.71 and $338.96, with an estimated average price of $315.3. The stock is now traded at around $230.59. The impact to a portfolio due to this purchase was 1.94%. The holding were 150,000 shares as of .

New Purchase: Burlington Stores Inc (BURL)

Armistice Capital, Llc initiated holding in Burlington Stores Inc. The purchase prices were between $139.89 and $175.74, with an estimated average price of $161.4. The stock is now traded at around $160.77. The impact to a portfolio due to this purchase was 1.72%. The holding were 200,000 shares as of .

New Purchase: The Home Depot Inc (HD)

Armistice Capital, Llc initiated holding in The Home Depot Inc. The purchase prices were between $168.61 and $192.39, with an estimated average price of $183.33. The stock is now traded at around $191.76. The impact to a portfolio due to this purchase was 1.18%. The holding were 112,000 shares as of .

Added: Target Corp (TGT)

Armistice Capital, Llc added to a holding in Target Corp by 300.00%. The purchase prices were between $65.53 and $80.32, with an estimated average price of $72.93. The stock is now traded at around $70.81. The impact to a portfolio due to this purchase was 1.32%. The holding were 400,000 shares as of .

Added: Assembly Biosciences Inc (ASMB)

Armistice Capital, Llc added to a holding in Assembly Biosciences Inc by 1028.00%. The purchase prices were between $17.7 and $24.93, with an estimated average price of $21.15. The stock is now traded at around $15.96. The impact to a portfolio due to this purchase was 1.11%. The holding were 1,128,000 shares as of .

Added: Frontdoor Inc (FTDR)

Armistice Capital, Llc added to a holding in Frontdoor Inc by 88.67%. The purchase prices were between $25.49 and $37.07, with an estimated average price of $30.42. The stock is now traded at around $40.79. The impact to a portfolio due to this purchase was 1.01%. The holding were 1,132,000 shares as of .

Added: AMAG Pharmaceuticals Inc (AMAG)

Armistice Capital, Llc added to a holding in AMAG Pharmaceuticals Inc by 76.57%. The purchase prices were between $11.29 and $17.05, with an estimated average price of $14.96. The stock is now traded at around $11.39. The impact to a portfolio due to this purchase was 1.01%. The holding were 3,316,000 shares as of .

Added: Adamas Pharmaceuticals Inc (ADMS)

Armistice Capital, Llc added to a holding in Adamas Pharmaceuticals Inc by 317.02%. The purchase prices were between $7.11 and $12.15, with an estimated average price of $9.01. The stock is now traded at around $5.73. The impact to a portfolio due to this purchase was 0.81%. The holding were 2,744,000 shares as of .

Added: AutoZone Inc (AZO)

Armistice Capital, Llc added to a holding in AutoZone Inc by 75.00%. The purchase prices were between $811.37 and $1024.12, with an estimated average price of $896.18. The stock is now traded at around $978.36. The impact to a portfolio due to this purchase was 0.67%. The holding were 28,000 shares as of .

Sold Out: Tempur Sealy International Inc (TPX)

Armistice Capital, Llc sold out a holding in Tempur Sealy International Inc. The sale prices were between $41.07 and $59.53, with an estimated average price of $53.92.

Sold Out: Stericycle Inc (SRCL)

Armistice Capital, Llc sold out a holding in Stericycle Inc. The sale prices were between $36.69 and $54.42, with an estimated average price of $45.08.

Sold Out: Regeneron Pharmaceuticals Inc (REGN)

Armistice Capital, Llc sold out a holding in Regeneron Pharmaceuticals Inc. The sale prices were between $372.08 and $439.57, with an estimated average price of $411.49.

Sold Out: Progenics Pharmaceuticals Inc (PGNX)

Armistice Capital, Llc sold out a holding in Progenics Pharmaceuticals Inc. The sale prices were between $4.02 and $4.91, with an estimated average price of $4.53.

Sold Out: TJX Companies Inc (TJX)

Armistice Capital, Llc sold out a holding in TJX Companies Inc. The sale prices were between $44.19 and $53.21, with an estimated average price of $49.78.

Sold Out: Alexion Pharmaceuticals Inc (ALXN)

Armistice Capital, Llc sold out a holding in Alexion Pharmaceuticals Inc. The sale prices were between $97.36 and $137.75, with an estimated average price of $123.89.



Here is the complete portfolio of ARMISTICE CAPITAL, LLC. Also check out:

1. ARMISTICE CAPITAL, LLC's Undervalued Stocks
2. ARMISTICE CAPITAL, LLC's Top Growth Companies, and
3. ARMISTICE CAPITAL, LLC's High Yield stocks
4. Stocks that ARMISTICE CAPITAL, LLC keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK